Aristides Armas Villalba, MD
Pulmonary Disease · San Antonio, TXNPI 1225559081
Payments from drug & device makers
Across 60 payments — averaging $86.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pulmonx Corporation$2K
- Pinnacle Biologics, Inc$1K
- Intuitive Surgical$922
- Fujifilm Sonosite, Inc.$448
- GSK$278
- AstraZeneca$197
- plus $631 from 15 others
What the payments were for
- Travel & lodging$2,47948%
- Food & beverage$2,23943%
- Education$4489%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pulmonx Corporation | 8 | $1,519 |
| Pinnacle Biologics, Inc | 5 | $1,170 |
| Intuitive Surgical | 4 | $922 |
| Fujifilm Sonosite, Inc. | 1 | $448 |
| GSK | 12 | $278 |
| AstraZeneca | 10 | $197 |
| Regeneron Healthcare Solutions, Inc. | 3 | $163 |
| ERBE USA Inc | 1 | $66 |
| Viatris Specialty LLC | 2 | $55 |
| AbbVie | 2 | $55 |
| Olympus America Inc. | 1 | $43 |
| Mallinckrodt Hospital Products Inc. | 2 | $39 |
| Shionogi Inc | 1 | $35 |
| Insmed, Inc. | 1 | $28 |
| Verona Pharma, Inc. | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Mylan Specialty L.p. | 1 | $23 |
| Sanofi | 1 | $23 |
| Boehringer Ingelheim | 1 | $20 |
| Bristol Myers Squibb | 1 | $18 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,165 in reported general payments places this provider in the 60th percentile of 904 pulmonary disease providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in San Antonio
- Charles AndrewsSan Antonio$17M
- Antonio AnzuetoSan Antonio$1.8M
- Diego Maselli CaceresSan Antonio$1.8M
- John HolcombSan Antonio$1.7M
- David MarksSan Antonio$1.3M
- Anoop NambiarSan Antonio$840K
- Rodolfo Estrada AnzuetoSan Antonio$324K
- Ali AbediSan Antonio$269K
- Ivan RosasHouston$13.8M
- Shahrukh KureishyMcKinney$12.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.